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Abstract Heme oxygenase-1 (HO-1) is induced under various
oxidative stress conditions, such as lipopolysaccharide (LPS)
insult. Induction of HO-1 by LPS is reported to be mediated
through interleukin-1L (IL-1L), rather than other inflammatory
cytokines in the mouse liver. However, we found that IL-1K/L
knockout (KO) mice responded well to LPS insult, as did wild-
type mice with respect to HO-1 mRNA induction (about 30-fold
increase). In contrast, tumor necrosis factor K KO (TNFKKO)
mice responded very weakly to LPS in the HO-1 mRNA
expression, but not metallothionein mRNA. Recent studies reveal
that nitric oxide from Kupffer cells is involved in HO-1 induction
in the liver produced by LPS. Therefore, nitrite and nitrate
concentrations in the liver were also measured and these
parameters did not increase in either IL-1KO or TNFKKO. In
addition, the phosphorylation of c-JUN N-terminal kinase
(JNK) and p38, but not extracellular signal-regulated kinase,
was very low in TNFKKO mice due to LPS administration. All
of these findings indicate that TNFK is a major candidate to
trigger HO-1 induction in response to LPS stimulation, and that
its message is likely transduced through JNK and p38
pathways. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Heme oxygenase-1 (HO-1) is a rate-limiting enzyme for
heme degradation and is known to be a stress marker because
of its rapid inductive response to various oxidative stresses
[1^4]. Lipopolysaccharide (LPS) is one of the well known
inducers of HO-1 in many di¡erent tissues or cell lines [5^8].
A mechanism to induce HO-1 by LPS has been shown to be
mediated by DNA binding activation of activated protein-1
(AP-1) [5,9], and interleukin-1L (IL-1L) elevated after LPS
administration is suggestive of being one of the major inter-
mediary cytokines in mouse liver [10,11]. Recently, nitric ox-
ide (NO) produced by LPS stimulation has been shown to
lead to HO-1 gene expression in the Kup¡er cell [11,12].
Gene-modi¢ed animals are a good tool to understand bio-
logical mechanisms in a whole body. However, no study on
the possible involvement of cytokines on HO-1 gene expres-
sion by LPS using cytokine de¢cient mice has previously been
carried out. We assumed that using these gene-modi¢ed ani-
mals would be useful for studying the mechanism of HO-1
mRNA induction by LPS since LPS produces various cyto-
kines that work as a network. Therefore, we used IL-1K/L
de¢cient (IL-1 knockout (KO) mouse) and tumor necrosis
factor K (TNFK) de¢cient mice (TNFKKO mouse) to com-
pare the e¡ect of LPS on HO-1 gene expression. In this study,
we also examined a possible role of NO to induce HO-1
mRNA expression. For this purpose, we determined nitrite
and nitrate (NOx) concentrations, the stable oxidation prod-
ucts of NO in the liver, after LPS administration. Addition-
ally, we investigated the changes in the mitogen-activated pro-
tein (MAP) kinase to the induction of HO-1 gene expression
evoked by LPS, which associates with AP-1 DNA binding
activation [13].
2. Materials and methods
2.1. Reagents
LPS from Escherichia coli serotype (O111:B4) was purchased from
Sigma Aldrich Japan (Tokyo, Japan). Deoxycytidine-5P-[K-32P]-
triphosphate (3000 Ci/mmol) and [Q-32P]adenosine-5P-triphosphate
(5000 Ci/mmol) were from Japan Isotope Association (Tokyo, Japan).
Complete1 protease inhibitor cocktail was from Roche Diagnostics
GmbH (Mannheim, Germany). Polyclonal antibodies against p44/42
MAP kinase, SAPK/c-JUN N-terminal kinase (JNK) or p38 MAP
kinase, phospho-SAPK/JNK (Thr183/Tyr185), phospho-p38 MAP ki-
nase (Thr180/Tyr182) and monoclonal antibody against phospho-p44/
42 MAP kinase (Thr202/Tyr204) were from Cell Signaling Technol-
ogy, Inc. (Beverly, MA, USA). All other reagents used were of the
highest grade commercially available.
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2.2. Animals and treatment
All animal experiments were carried out under the control of the
Regulation of the Committee of Animal Care and Welfare of Showa
University. The IL-1KO mouse was established by Horai et al. [14]
and the TNFKKO mouse was established by Tagawa et al. [15].
Balb/c mice were purchased from Shizuoka Laboratory Animal
Center (Shizuoka, Japan) and mated with either IL-1KO or
TNFKKO. Wild-type, homozygous and heterozygous progenies were
selected by their respective gene expressions and the lines for wild-type
or homozygous animals were established. LPS was dissolved in saline
and injected intraperitoneally at the dose of 0.1 mg/kg.
2.3. RNA extraction and Northern blot
Total RNA was isolated from the liver of each mouse using the acid
GTC^phenol^chloroform extraction method [16] as previously de-
scribed [2]. Total RNA (20 Wg) was fractionated by electrophoresis
on 1% agarose gel followed by transfer onto a nylon membrane. The
RNA blot was hybridized with 32P-labeled cDNA for HO-1 (1.1 kb,
BamHI fragment of pMp32cod) and metallothionein (MT)-1 (0.4 kb,
HindIII/EcoRI fragment of pmMT-1), and oligonucleotide for mouse
18S ribosomal RNA (5P-ACGGTATCTGATCGTCTTCGAACC-3P ;
this sequence corresponds to the complement of nucleotides 1044^
1067 of the mouse gene for 18S rRNA). The hybridization levels
were quantitated with a bio-imaging analyzer (BAS3000, Fuji Photo
Film Co., Tokyo, Japan).
2.4. Cytokine concentrations
IL-1L, IL-6 and TNFK concentrations in mouse serum were deter-
mined using enzyme-linked immunosorbent assay kits (IL-1L and IL-
6, Endogen, Woburn, MA, USA; TNFK, Biosource, Camarillo, CA,
USA).
2.5. NOx concentration
NOx in the liver was determined by the method of Yamada et al.
[17] using the NO detector^high-performance liquid chromatography
system (ENO-10, Eicom, Kyoto, Japan). Livers were perfused with
saline containing 1 mM EDTA and 0.1% aprotinin and immediately
stored in 20% glycerol solution. The tissue was homogenized with at
least four volumes of 20% glycerol solution, and the supernatant after
centrifugation of the homogenate was used as a sample to measure
NOx. NOx in the supernatant was separated by a reverse-phase sep-
aration column packed with polystyrene polymer (NO-PAK, 4.6U50
mm, Eicom, Kyoto, Japan), and nitrate was reduced to nitrite in a
reduction column packed with copper-plated cadmium ¢llings (NO-
RED, Eicom, Kyoto, Japan). The nitrite concentration was measured
by the reaction with Griess reagent to form a purple azodye in a
reaction coil.
2.6. Phosphorylation of p38, JNK and extracellular signal-regulated
kinase (ERK)
Liver was perfused with 10 mM Tris^HCl (pH 7.4) containing 1 mM
EDTA, 250 mM sucrose, 1 mM APMSF, 2 Wg/ml aprotinin, 10 mM
p-nitrophenyl phosphate, 20 mM L-glycerophosphate, 50 WM sodium
orthovanadate and 10 mM sodium molybdate and homogenized with
10 volumes of the homogenizing bu¡er (20 mM Tris^HCl (pH 7.4)
containing 150 mM NaCl, 1% NP-40, 100 Wg/ml DNase I, 50 Wg/ml
RNase A, 1 mM APMSF, 10 mM p-nitrophenyl phosphate, 20 mM
L-glycerophosphate, 50 WM sodium orthovanadate and 10 mM
sodium molybdate and Complete1 protease inhibitor cocktail). The
homogenized solution was centrifuged for 20 min at 15 000 rpm and
the supernatant was used for the immunoblot analysis. Protein con-
centration was determined by the method of Bradford [18], using a
protein reagent (Bio-Rad Labs., Hercules, CA, USA).
The supernatant fraction (25 Wg protein) was solubilized in 2% SDS
and the proteins were separated by polyacrylamide gel electrophoresis
(3% stacking gel, 10% separating gel) according to the method of
Laemmli [19]. After electrophoresis, the proteins were transferred to
polyvinylidene di£uoride membranes (Japan Genetics Co., Tokyo,
Japan) at 80 mA for 50 min. Western blots were performed using
polyclonal antibodies against p44/42 MAP kinase, SAPK/JNK or
p38 MAP kinase, phospho-SAPK/JNK (Thr183/Tyr185), phospho-
p38 MAP kinase (Thr180/Tyr182) and monoclonal antibody against
phospho-p44/42 MAP kinase (Thr202/Tyr204). Signal was detected
using chemiluminescence (ECL, Amersham Pharmacia Biotech, Buck-
inghamshire, UK). Molecular weight was calculated with prestained
SDS^PAGE standards (Bio-Rad Labs., Hercules, CA, USA) that was
applied to the same gel run samples.
2.7. Statistical analysis
Data were subjected to statistical analysis by the Kruskal^Wallis
non-parametric analysis of variance test followed by Dunn’s multiple
comparison test. The accepted level of signi¢cance was set at P6 0.05.
3. Results
We ¢rst examined the dose-dependent e¡ects of LPS on
HO-1 gene expression in wild-type mice livers and found
that there were no signi¢cant di¡erences in HO-1 mRNA
among the doses of 0.1, 0.5 and 1 mg/kg at 2 h after the
administration (data not shown). Therefore, we chose 0.1
mg/kg of LPS in this study. Fig. 1 represents the e¡ect of
LPS on HO-1 gene expression in IL-1KO, TNFKKO and
wild-type mice livers. We also examined the response of MT
mRNA, another stress responsive protein, under the same
experimental conditions. Unexpectedly, HO-1 mRNA expres-
sion in response to LPS in the IL-1KO liver showed almost
the same level as that seen in the wild-type mice. In contrast,
TNFKKO mice showed a very weak HO-1 gene expression,
but not MT gene, in response to LPS. Namely, LPS did not
produce the increase of HO-1 gene expression, but rather
enhanced MT mRNA expression in the TNFKKO mice in a
manner similar to that of the wild-type mice livers. In IL-1KO
mice, LPS tended to increase MT response to a greater degree
than that observed in the wild-type mice.
Under the same experimental conditions, we measured IL-
1L, IL-6 and TNFK concentrations in the mice sera (Fig. 2).
As shown in Fig. 2, TNFKKO mice showed very limited abil-
ity to produce IL-1L in response to LPS and responded to
Fig. 1. E¡ect of LPS on HO-1 and MT gene expression in wild-
type, IL-1KO and TNFKKO mouse livers. LPS (0.1 mg/kg) was in-
jected intraperitoneally and livers were collected at 2 h after treat-
ment. A: Northern blot analysis was performed. B: Blots for HO-1
and MT mRNA were semi-quanti¢ed and normalized with that for
18S ribosomal RNA. Symbols represent the mean þ S.E.M. for sev-
en or 10 mice. *Signi¢cantly di¡erent from controls at P6 0.05.
#Signi¢cantly di¡erent from wild-type mice treated with LPS at
P6 0.05.
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about 1/10 of IL-6 production when compared to those pro-
duced in the wild-type mice. In contrast, LPS was able to
increase the IL-6 content three-fold, but it decreased TNFK
to 40% of the control value, in IL-1KO mice compared to that
seen in the wild-type mice.
In order to clarify the possible role of TNFK in the HO-1
gene expression induced by LPS, we examined the e¡ects LPS
on heterozygous and homozygous animals (Fig. 3). As shown
in Fig. 3, we found that the magnitude of HO-1 mRNA ex-
pression in TNFK (+/3) mice treated with LPS was reduced
to about 80% of the wild-type mice when examined at 2 h
after the administration.
Recently, it has been reported that NO produced in the
Kup¡er cells after LPS stimulation is a strong mediator for
the induction of HO-1 mRNA [11,12]. Then, nitrite and ni-
trate concentrations were measured in the mouse liver of the
stimulation with LPS. As shown in Fig. 4, nitrate was the
major NO product and was 100 times more abundant than
nitrite in the liver of wild-type, IL-1KO as well as TNFKKO
mice. In wild-type mice livers, nitrate level was increased to
about two-fold the control levels after stimulation with LPS.
However, neither IL-1KO nor TNFKKO mouse livers showed
any increase of nitrate levels in the liver. On the other hand,
nitrite levels in the wild-type, IL-1KO and TNFKKO mouse
livers were not changed appreciably after LPS stimulation.
Nitrite concentrations in the liver of IL-1KO and TNFKKO
controls were higher than that of the wild-type mice; however,
again the nitrite concentration was only about 1/100 of the
nitrate concentration in the liver. Under the same experimen-
tal conditions, we also measured plasma NOx concentrations
and found that there was no alteration of the product in any
mice (data not shown).
Since LPS lacked the induction of HO-1 mRNA in
TNFKKO mice, we ¢nally examined the changes in MAP ki-
nase resulting in AP-1 DNA binding activation, which have
been shown to promote an increase in HO-1 gene transcrip-
tion. As shown in Fig. 5, we found that TNFKKO mice ex-
hibited lower levels of the phosphorylated JNK and p38. In
contrast, LPS increased ERK phosphorylation in TNFKKO
mice, as well as in wild-type mice.
4. Discussion
It is di⁄cult to identify the factor that plays the most prom-
inent role in HO-1 gene expression during LPS stimulation
because LPS stimulates various factors, including in£amma-
tory cytokines and NO, which have been shown to induce
HO-1, individually [20]. The present study has shown that
Fig. 2. E¡ect of LPS on various cytokines in mouse serum. Experimental conditions were the same as in Fig. 1. Serum cytokine concentrations
were determined as described in Section 2. Symbols represent the mean þ S.E.M. for three or four mice. *Signi¢cantly di¡erent from controls at
P6 0.05. #Signi¢cantly di¡erent from wild-type mice treated with LPS at P6 0.05.
Fig. 3. E¡ect of LPS on HO-1 mRNA in TNFK(3/3) and
TNFK(+/3) mouse livers. A: Northern blot analysis was performed.
B: Blots for HO-1 were semi-quanti¢ed and normalized with that
for 18S ribosomal RNA. Symbols represent the mean þ S.E.M. for
¢ve or six mice. *Signi¢cantly di¡erent from controls at P6 0.05.
#Signi¢cantly di¡erent from wild-type mice treated with LPS at
P6 0.05.
Fig. 4. E¡ect of LPS on nitrate and nitrite concentrations in wild-
type, IL-1KO and TNFKKO mouse livers. Nitrate and nitrite con-
centrations in mouse livers were detected as described in Section 2.
Bars represent the mean þ S.E.M. for four or six mice. *Signi¢cantly
di¡erent from controls at P6 0.05.
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TNFK is one of the key cytokines to produce HO-1 gene
expression under LPS stimulation in mouse livers. Previous
studies revealed the involvement of IL-1L and/or NO, released
from Kup¡er cells, not TNFK or IL-6 in HO-1 mRNA accu-
mulation after LPS stimulation [10^12]. However, the
TNFKKO mouse has only a weak response to IL-1L and
NO production after LPS administration. Therefore, IL-1L
and/or NOs might work only marginally to induce HO-1
mRNA.
We also studied e¡ects of neutralizing antibodies against
either IL-1L or TNFK to examine which cytokine is involved
in HO-1 gene expression in response to LPS (data not shown).
Neutralizing TNFK antibody suppressed HO-1 mRNA induc-
tion about 30% and IL-1L antibody by about 10% in the wild-
type mice. This indicates that the results obtained by employ-
ing cytokine KO mice are basically consistent with what has
occurred in wild-type mice although neutralizing antibodies
do not work as e¡ectively as what we expected.
It has been reported that MT induction by LPS is regulated
through IL-6 [21]. LPS-mediated elevation of IL-6 content in
IL-1KO mice was higher than the wild-type animals, which
possibly leads to the enhanced MT expression in the former
mice. However, TNFKKO mice showed a similar response of
MT mRNA to that in wild-type mice with a lower amount of
IL-6 in the serum. Therefore, the present study indicates that
there are other factors that cause MT induction in addition to
IL-6. In this respect, however, further study will be needed.
The increase of nitrate in the wild-type mouse evoked by
LPS was not to as great an extent as compared to that of
HO-1 mRNA induction. Furthermore, IL-1KO mice that ex-
pressed high HO-1 mRNA by LPS administration did not
produce a high NOx concentration. Taken together, NO
may have a limited role in the induction of HO-1 mRNA
by LPS when compared to TNFK in the murine liver,
although previous studies have shown the importance of
NO in vivo and in vitro [11,22].
LPS initially binds to the CD14 and toll-like receptor at the
cell surface and activates MAP kinase pathways [13,23]. It is
also reported that HO-1 gene expression by LPS stimulation is
mediated by the activation of a transcription factor, AP-1
[5,9,20]. The present study suggests that p38 and JNK are
involved in the signal transduction of LPS, which activates
AP-1 followed by HO-1 gene expression.
The present ¢ndings employed with cytokine KO mice sup-
port the hypothesis that TNFK plays a more critical role in
HO-1 mRNA induction by LPS in mouse livers than IL-1L
and NOx, and this process is mediated by p38 and JNK.
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Fig. 5. E¡ect of LPS on MAP kinases in wild-type and TNFKKO
mouse livers. Mice were treated with LPS (0.1 mg/kg or 1.0 mg/kg)
and the livers were collected at 1 h after the treatment. Immuno-
blotting analysis was investigated as described in Section 2.
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